Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01278173 · ClinicalTrials.gov registry record · Phase 4
A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)
A Phase 4 study, sponsored by Lundbeck.
- Completed
- Registry status
- Phase 4
- Development phase
- 65
- Enrollment target
NCT01278173 is a Phase 4 study that has completed, run by Lundbeck. The registered enrollment target is 65 participants.
The verdict
NCT01278173, a Phase 4 study, has completed, sponsored by Lundbeck.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the change in visual fields by means of automated static perimetry and to evaluate the change in retinal structure by means of spectral domain optical coherence tomography (SD-OCT) in adult patients with refractory complex partial seizures (CPS) being treated with vigabatrin (Sabril®)
Interventions
- DRUG Sabril
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2010-12 |
| Est. Completion | 2015-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01278173
The ClinicalTrials.gov registry entry for NCT01278173 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lundbeck, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sabril is the first listed.
NCT01278173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01278173 about?
NCT01278173 is a clinical study titled "A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)". The purpose of the study is to evaluate the change in visual fields by means of automated static perimetry and to evaluate the change in retinal structure by means of spectral domain optical coherence tomography (SD-OCT) in adult patients with refractory complex partial seizures (CPS) being treated ...
What is the current status of trial NCT01278173?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 65 participants. The study started on 2010-12. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01278173?
The interventions under investigation include: Sabril (DRUG).
Who is sponsoring clinical trial NCT01278173?
This trial is sponsored by Lundbeck, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.